“Performan\u0163ele v\u00e2nz\u0103rilor \u00eenregistrate de Grupul Roche \u00een cel de-al treilea trimestru sunt \u00een conformitate cu a\u015ftept\u0103rile, \u015fi suntem \u00een continuare pe calea cea buna \u00een \u00eendeplinirea obiectivelor propuse pentru acest an. Roche \u015fi-a consolidat, \u00een mod special, portofoliul \u00een cancerul de s\u00e2n, prin lansarea cu succes \u00een Statele Unite \u015fi Elve\u0163ia a celei mai noi molecule destinate cancerului mamar, dar \u015fi prin depunerea spre aprobare a unui anticorp monoclonal conjugat \u00een Statele Unite \u015fi \u00een Europa”, a declarat Severin Schwan, CEO al grupului Roche, cu privire la rezultatele financiare din primele 9 luni ale anului 2012.<\/p>\n
V\u00e2nz\u0103rile Diviziei de Farmaceutice a grupului Roche au crescut cu 4% \u00een primele 9 luni ale anului 2012, p\u00e2n\u0103 la 26.2 miliarde de franci elve\u0163ieni, \u00een mare parte datorit\u0103 portofoliului de produse oncologice care a \u00eenregistrat o cre\u015ftere de 9%. \u00cen linia de cercetare \u015fi dezvoltare s-au \u00eenregistrat deja 11 rezultate pozitive din 14 studii aflate \u00een faze finale. V\u00e2nz\u0103rile Diviziei de Diagnostic a grupului Roche au crescut cu 4% p\u00e2n\u0103 la 7.5 miliarde de franci elve\u0163ieni. Aceast\u0103 cre\u015ftere s-a datorat produselor pentru laboratoarele clinice \u015fi a fost sus\u0163inut\u0103 \u00een principal de Professional Diagnostics (+9%) \u015fi Tissue Diagnostics (+15%).<\/p>\n
Se a\u015fteapt\u0103 ca v\u00e2nz\u0103rile Grupului \u015fi ale Diviziei de Farmaceutice s\u0103 creasc\u0103 cu o singur\u0103 cifr\u0103 la sf\u00e2r\u015fitul anului. Astfel, se estimeaz\u0103 c\u0103 v\u00e2nz\u0103rile Diviziei de Diagnostic vor \u00eenregistra cre\u015fteri semnificative peste media pie\u0163ei, datorit\u0103 lans\u0103rilor de noi produse \u00een toate domeniile \u00een care activeaz\u0103 aceast\u0103 divizie.<\/p>\n","protected":false},"excerpt":{"rendered":"
Concernul farmaceutic elve\u0163ian Roche anun\u0163\u0103 o cre\u015ftere a v\u00e2nz\u0103rilor globale \u00een primele 9 luni ale anului 2012, cu 7% \u00een franci elve\u0163ieni, p\u00e2n\u0103 la 33,7 miliarde franci elve\u0163ieni, la o rat\u0103 de schimb constant\u0103. Aceast\u0103 cre\u015ftere s-a datorat \u00een special portofoliului de oncologie, dar \u015fi a produselor Diviziei de Diagnostic, destinate laboratoarelor clinice.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[8088,8760,518,8623],"class_list":["post-58122","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-farma","tag-oncologice","tag-rezultate","tag-roche"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/58122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=58122"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/58122\/revisions"}],"predecessor-version":[{"id":74268,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/58122\/revisions\/74268"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=58122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=58122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=58122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}